Detailansicht

Wissensnetz

Person

Niels Halama (1977-)

Arzt

Name	Niels Halama
Zeit	1977- (Lebensdaten)
Ort	Heidelberg (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Beziehung	Universitätsklinikum Heidelberg BioQuant Nationales Centrum für Tumorerkrankungen
Weitere Angaben	Diss. Medizinische Fakultät; Assistenzarzt, Laborleiter AG Jäger, Medizinische Onkologie, NCT, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	13087325X
Datensatz-ID	13087325X
Beteiligt an alle anzeigen Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy Generating evidence for diagnosis and therapy of RarE LIVEr disease: the RELIVE Initiative for systematic reviews and meta-analyses A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial Bowel inflammation in cancer patients: the microbiome, antibiotics and interleukin-9 Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer Immunotherapy of Colorectal Cancer Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study The next age of immunotherapy: optimisation, stratification and therapeutic synergies IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure Topography of cancer-associated immune cells in human solid tumors A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells In silico SNP analysis of the breast cancer antigen NY-BR-1 Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients Immunotherapy of Colorectal Cancer Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue Kandidatengen- und Mutationsanalyse bei diabetischer Nephropathie

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Niels Halama (1977-)

Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma

Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy

Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy

Generating evidence for diagnosis and therapy of RarE LIVEr disease: the RELIVE Initiative for systematic reviews and meta-analyses

A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial

Bowel inflammation in cancer patients: the microbiome, antibiotics and interleukin-9

Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer

Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient

Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer

Immunotherapy of Colorectal Cancer

Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study

The next age of immunotherapy: optimisation, stratification and therapeutic synergies

IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells

Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure

Topography of cancer-associated immune cells in human solid tumors

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells

In silico SNP analysis of the breast cancer antigen NY-BR-1

Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients

Immunotherapy of Colorectal Cancer

Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases

Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue

Kandidatengen- und Mutationsanalyse bei diabetischer Nephropathie